Abhilash D. Pandya
- Reseacher; PhD
- +47 22 78 18 59
Abhilash completed his masters in molecular biology in Sweden and the USA. He has vast experience in histology and immunology research, and previously studied regulatory proteins in first trimester trophoblasts and other human pathophysiological tissues. He identified a novel subset of inflammatory Natural Killer cells (NK17/NK1) in patients with a neurodegenerative disease - Multiple Sclerosis. He has been part of our group since June 2016, and working on novel approaches in cancer therapy (targeted therapy) using drug-loaded nanoparticles (NPs). He studies toxicity, biodistribution and treatment response in different in vivo mice tumor models. He is also determining NP induced immune response and examining presence of immune cells in the tumors.
Publications 2024
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
Br J Cancer, 131 (10), 1656-1667
DOI 10.1038/s41416-024-02875-5, PubMed 39390250
Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants
Int J Nanomedicine, 19, 3009-3029
DOI 10.2147/IJN.S450283, PubMed 38562610
Publications 2023
Liver X receptors induce antiproliferative effects in basal-like breast cancer
Mol Oncol, 17 (10), 2041-2055
DOI 10.1002/1878-0261.13476, PubMed 37341140
Publications 2022
Corrigendum to "Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft", [Journal of Control Release, 293 (2019) 183-192]
J Control Release, 349, 1
DOI 10.1016/j.jconrel.2022.06.040, PubMed 35792388
Publications 2021
Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
Nanomaterials (Basel), 11 (5)
DOI 10.3390/nano11051140, PubMed 33924869
Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells
Int J Pharm, 597, 120217
DOI 10.1016/j.ijpharm.2021.120217, PubMed 33486035
Publications 2020
Drug-Loaded Photosensitizer-Chitosan Nanoparticles for Combinatorial Chemo- and Photodynamic-Therapy of Cancer
Biomacromolecules, 21 (4), 1489-1498
DOI 10.1021/acs.biomac.0c00061, PubMed 32092254
Physicochemical Characterization, Toxicity and In Vivo Biodistribution Studies of a Discoidal, Lipid-Based Drug Delivery Vehicle: Lipodisq Nanoparticles Containing Doxorubicin
J Biomed Nanotechnol, 16 (4), 419-431
DOI 10.1166/jbn.2020.2911, PubMed 32970975
Publications 2019
Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
Int J Nanomedicine, 14, 6269-6285
DOI 10.2147/IJN.S208938, PubMed 31496685
Publications 2018
Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft
J Control Release, 293, 183-192
DOI 10.1016/j.jconrel.2018.11.029, PubMed 30529259
Publications 2016
Tube formation in the first trimester placental trophoblast cells: Differential effects of angiogenic growth factors and fatty acids
Cell Biol Int, 40 (6), 652-61
DOI 10.1002/cbin.10601, PubMed 26992362
Publications 2014
Expression of the T cell-specific adapter protein in human tissues
Scand J Immunol, 80 (3), 169-79
DOI 10.1111/sji.12199, PubMed 24910151
Publications 2011
Identification of human NK17/NK1 cells
PLoS One, 6 (10), e26780
DOI 10.1371/journal.pone.0026780, PubMed 22039549